Brookline Capital Management Weighs in on Adial Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ADIL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Rises By 11.4% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Declines By 37.4% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 25,800 shares, a decline of 37.4% from the November 30th total of 41,200 shares. Based on an average trading volume of 96,300 shares, the short-interest ratio […]